Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06093633 · ClinicalTrials.gov registry record

A Prospective Study to Evaluate the WP in Comparison to PSG in Patients Suspected of Sleep Disorders

A clinical trial of Sleep Disorder, sponsored by Itamar-Medical, Israel.

Recruiting
Registry status
600
Enrollment target
3
Study locations

NCT06093633 is a study of Sleep Disorder that is actively recruiting participants, run by Itamar-Medical, Israel. The registered enrollment target is 600 participants, above the 135-participant average among 22 other Sleep Disorder trials with a reported enrollment target (344% higher). The trial reports 3 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06093633, a study of Sleep Disorder, is actively recruiting participants, sponsored by Itamar-Medical, Israel.

RECRUITING
Registry status
600 participants
Enrollment target
3
Study locations

Study Summary

The current study is a prospective blinded study to collect data regarding the performance of the WP device in detecting sleep disorders. For that purpose, the WP with finger probe and chest sensor will be worn by the subject simultaneous to PSG in a sleep study at the clinical sleep lab. A PSG system will be recording the PSG data.

Conditions Studied

Study Locations (3)

Maryland

  • Johns Hopkins Bayview Asthma and Allergy Center - Baltimore
  • University of Maryland St. Joseph Medical Group, Pulmonary Care & Sleep Medicine - Towson

Other

  • Tel-Aviv Medical Center - Tel Aviv

Trial Details

FieldValue
Enrollment Target 600 participants
Start Date 2022-09-19
Est. Completion 2025-10-01

Sponsor

Itamar-Medical, Israel

5 total trials

What the Registry Record Tells You About NCT06093633

The ClinicalTrials.gov registry entry for NCT06093633 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 135-participant average among 22 other Sleep Disorder trials with a reported enrollment target (344% higher). The listed sponsor is Itamar-Medical, Israel, which has 5 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Sleep Disorder appearing as the primary indexed condition, and to 0 interventions.

NCT06093633 reports 3 study locations spanning 2 distinct geographic areas - top geographies include Maryland, Other.

Frequently Asked Questions

What is clinical trial NCT06093633 about?

NCT06093633 is a clinical study titled "A Prospective Study to Evaluate the WP in Comparison to PSG in Patients Suspected of Sleep Disorders". The current study is a prospective blinded study to collect data regarding the performance of the WP device in detecting sleep disorders. For that purpose, the WP with finger probe and chest sensor will be worn by the subject simultaneous to PSG in a sleep study at the clinical sleep lab. A PSG syst...

What is the current status of trial NCT06093633?

This trial is currently recruiting. The enrollment target is 600 participants. The study started on 2022-09-19. Estimated completion is 2025-10-01.

What conditions does trial NCT06093633 study?

This clinical trial studies the following conditions: Sleep Disorder.

Who is sponsoring clinical trial NCT06093633?

This trial is sponsored by Itamar-Medical, Israel, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06093633 being conducted?

This trial has 3 study locations across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sleep Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.